Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Malignant Melanoma

Free Subscription 06.10.2025 1 Am J Dermatopathol 3 Ann Surg Oncol 1 Anticancer Res 1 BMC Cancer 1 Br J Dermatol 2 Cancer Lett 1 J Am Acad Dermatol 2 J Clin Oncol 1 J Immunol 1 J Surg Oncol 1 Melanoma Res 1 Nat Med 1 Nat Rev Cancer

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. HE LJ, Hornick JL, Russell-Goldman E
   Methylthioadenosine Phosphorylase (MTAP) and p16 Expression in Melanocytic Nevi and Melanoma with Molecular Correlation.
   Am J Dermatopathol. 2025 Sep 26. doi: 10.1097/DAD.0000000000003139.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. MADDINENI S, Dizon MP, Muralidharan V, Young LA, et al
   Correction: Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma.
   Ann Surg Oncol. 2025 Sep 29. doi: 10.1245/s10434-025-18434.
   PubMed        
   
   
3. FAROOQ MS, Shafique N, Karakousis GC
   ASO Author Reflections: Single-Dose Neoadjuvant Pembrolizumab in Resectable Metastatic Melanoma.
   Ann Surg Oncol. 2025 Sep 29. doi: 10.1245/s10434-025-18456.
   PubMed        
   
   
4. PAPAI E, Ntoh K, Zhang L, Yu JQ, et al
   The Utility of Preoperative PET/CT in Patients with Clinically High-Risk Melanoma.
   Ann Surg Oncol. 2025 Sep 25. doi: 10.1245/s10434-025-18096.
   PubMed         Abstract available
   
   

   
   Anticancer Res

5. ANESTOPOULOS I, Paraskevaidis I, Kyriakou S, Trafalis DT, et al
   Isothiocyanates Enhance the Anti-melanoma Effect of Entinostat Through Modulation of Apoptosis and HDACs' Expression Patterns in an In Vitro Model of Human Malignant Melanoma.
   Anticancer Res. 2025;45:4151-4167.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. MO L, Jia M, Wu Q, Xu Q, et al
   CDC6 as a pan-cancer immunological and prognostic biomarker and its role in suppressing melanoma malignancy.
   BMC Cancer. 2025;25:1426.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

7. FISCHER GM, Fang R, Xu S, Karkempetzaki AI, et al
   Loss of TET2 Facilitates Aggressive Behavior in Cutaneous Melanoma by Inducing PGC1alpha/Oxidative Phosphorylation (OXPHOS).
   Br J Dermatol. 2025 Sep 27:ljaf378. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Cancer Lett

8. WANG C, Han L, Zhang J, Ji Q, et al
   Radiotherapy in combination with PD-1 and TIGIT blockade mediate antitumor abscopal effects and immune memory via CD8(+) T cells.
   Cancer Lett. 2025;631:217935.
   PubMed         Abstract available
   
   
9. CHEN Y, Wang X, Li H, Zhang Z, et al
   Oncoprotein SND1-enriched exosomes facilitate melanoma lung metastasis by regulating CD47-SIRPalpha-mediated macrophage reprogramming.
   Cancer Lett. 2025 Sep 25:218037. doi: 10.1016/j.canlet.2025.218037.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

10. BRANCACCIO G, Moscarella E, Scharf C, Briatico G, et al
    Older Age as an Independent Risk Factor for Recurrence in Stage II Cutaneous Melanoma.
    J Am Acad Dermatol. 2025 Sep 24:S0190-9622(25)02882.
    PubMed        
    
    

    
    J Clin Oncol

11. WILSON MA, Shoushtari AN
    Bridging the Gap: Incorporating Lifileucel Into Management of Advanced PD-1 Blockade Resistant Melanomas.
    J Clin Oncol. 2025 Oct 3:JCO2501396. doi: 10.1200/JCO-25-01396.
    PubMed        
    
    
12. VILE RG
    Fusing Oncolytic Virotherapy With Cancer Immunotherapy to Treat Therapy-Resistant Melanoma.
    J Clin Oncol. 2025 Sep 25:JCO2501890. doi: 10.1200/JCO-25-01890.
    PubMed        
    
    

    
    J Immunol

13. REINARTZ DM, Escamilla-Rivera V, Shao M, Tribble SL, et al
    Impact of absent in melanoma 2 on head and neck squamous cell carcinoma development.
    J Immunol. 2025 Oct 3:vkaf224. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

14. HANSEN SM, Jensen MB, Bidstrup PE, Johansen C, et al
    Identification of Sub-Groups of Patients Surgically Treated for Melanoma With Affected Health-Related Quality of Life and Psychosocial Well-Being.
    J Surg Oncol. 2025 Sep 29. doi: 10.1002/jso.70104.
    PubMed         Abstract available
    
    

    
    Melanoma Res

15. DAVIES L, Skepastianos V, Palazi C, Skepastianos G, et al
    Contralateral axillary sentinel lymph node in chest wall melanoma: first documented case and narrative review of the literature.
    Melanoma Res. 2025 Sep 26. doi: 10.1097/CMR.0000000000001065.
    PubMed         Abstract available
    
    

    
    Nat Med

16. LONG GV, Nair N, Marbach D, Scolyer RA, et al
    Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma: the randomized phase 1b/2 Morpheus-Melanoma trial.
    Nat Med. 2025 Sep 24. doi: 10.1038/s41591-025-03967.
    PubMed         Abstract available
    
    

    
    Nat Rev Cancer

17. LOPEZ-HERNANDEZ A, Ortega-Del Vecchyo D
    Discovering genetic interactions that cause melanoma in a non-model species.
    Nat Rev Cancer. 2025 Sep 24. doi: 10.1038/s41568-025-00884.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.